Mass distribution of azithromycin to children 1 to 59 months of age has been shown to reduce childhood all-cause mortality in some sub-Saharan African regions, with the largest reduction seen among ...
Please provide your email address to receive an email when new articles are posted on . SALT LAKE CITY — Early azithromycin use did not affect hematologic relapse among pediatric hematopoietic stem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results